A validated imaging platform taking its own products to market Optiscan Imaging Limited ASX: OIL INVESTOR PRESENTATION Important notice This presentation has been prepared by Optiscan Imaging Limited (OIL or the Company) and approved for release by Regulatory statements the Board of Optiscan....
Bell Potter Healthcare Conference Presentation
Filed with ASX · · 11 pages · English
Summary by 6ix AI
Optiscan Imaging Limited presented at the Bell Potter Healthcare Conference, outlining its transition from a technology supplier to a product company with two human FDA submissions filed and manufacturing capabilities established. The presentation highlights the company's proven technology, which is now marketed under its own name, and discusses the anticipated regulatory clearances for its devices.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Optiscan Imaging Limited on 6ix
In the deck
Story so far
Earlier from Optiscan Imaging
- Optiscan Strengthens Board with Appointment of Russell Low
- Notification of cessation of securities - OIL
- Quarterly Activities/Appendix 4C Cash Flow Report
- Optiscan Lodges U.S. FDA 510(k) Submission for InVue
- Optiscan Lodges U.S. FDA 510(k) Submission for InForm
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging